Thermo Fisher Scientific Inc. (TMO)
NYSE · Healthcare
Thermo Fisher Scientific Inc. Cash Flow 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Operating Cash Flow | 7.82B | 8.67B | 8.41B | 9.15B | 9.31B | 8.29B | 4.97B | 4.54B | 4.00B | 3.26B | 2.94B | 2.62B | 2.01B | 2.04B | 1.69B | 1.50B | 1.66B | 1.42B | 1.48B |
| Depreciation & Amort. | — | — | — | — | — | — | — | 2.27B | 2.03B | 1.76B | 1.69B | 1.68B | 999.9M | 983.7M | 859.6M | 739.7M | 762.9M | 792.7M | 756.8M |
| Investing Activities | |||||||||||||||||||
| Capital Expenditure | 1.52B | 1.40B | 1.48B | 2.24B | 2.52B | 1.47B | 926.0M | 758.0M | 508.0M | 444.0M | 423.0M | 427.6M | 282.4M | 315.1M | 260.9M | 245.4M | 200.0M | 264.4M | 175.5M |
| Free Cash Flow | 6.29B | 7.27B | 6.93B | 6.91B | 6.79B | 6.82B | 4.05B | 3.79B | 3.50B | 2.81B | 2.52B | 2.19B | 1.73B | 1.72B | 1.43B | 1.25B | 1.46B | 1.16B | 1.31B |
| Financing Activities | |||||||||||||||||||
| Dividends Paid | 636.0M | 583.0M | 523.0M | 455.0M | 395.0M | 337.0M | 297.0M | 266.0M | 237.0M | 238.0M | 241.0M | 234.8M | 216.2M | 142.2M | 0 | — | — | — | — |
| Stock Buybacks | 3.00B | 4.00B | 3.00B | 3.00B | 2.00B | 1.50B | 1.50B | 500.0M | 750.0M | 1.25B | 500.0M | 0 | 89.8M | 1.15B | 1.34B | 1.01B | 414.6M | 187.4M | 898.0M |
Thermo Fisher Scientific Inc. Cash Flow — FAQ
Thermo Fisher Scientific Inc. (TMO) cash flow over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMO's cash flow history?
The chart and table above show Thermo Fisher Scientific Inc.'s cash flow by year and by quarter, including the growth rate.